Benign Growth For China Shineway Pharmaceutical Group Limited (HKG:2877) Underpins Its Share Price

Simply Wall St.2025-12-24

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") above 13x, you may consider China Shineway Pharmaceutical Group Limited (HKG:2877) as an attractive investment ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2593440711?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2025-12-24 06:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593440711","market":"sg","top_or_hot":-1,"title":"Benign Growth For China Shineway Pharmaceutical Group Limited (HKG:2877) Underpins Its Share Price","media":"Simply Wall St.","content":"<div>\n<p>When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") above 13x, you may consider China Shineway Pharmaceutical Group Limited (HKG:2877) as an attractive investment ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/benign-growth-for-china-shineway-pharmaceutical-group-limite\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Benign Growth For China Shineway Pharmaceutical Group Limited (HKG:2877) Underpins Its Share Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBenign Growth For China Shineway Pharmaceutical Group Limited (HKG:2877) Underpins Its Share Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-24 06:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/benign-growth-for-china-shineway-pharmaceutical-group-limite><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") above 13x, you may consider China Shineway Pharmaceutical Group Limited (HKG:2877) as an attractive investment ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/benign-growth-for-china-shineway-pharmaceutical-group-limite\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02877","symbol_name":"神威药业","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/benign-growth-for-china-shineway-pharmaceutical-group-limite","article_id":"2593440711","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2877/china-shineway-pharmaceutical-group-shares/news/benign-growth-for-china-shineway-pharmaceutical-group-limite","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2593440711","pubTimestamp":1766529357,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") above 13x, you may consider...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"02877":"神威药业","BK1606":"中医药概念","BK1191":"制药"},"translate_title":"神威药业集团有限公司（HKG：2877）的良性增长支撑了其股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02877":1.5},"content_text":"When close to half the companies in Hong Kong have price-to-earnings ratios (or \"P/E's\") above 13x, you may consider China Shineway Pharmaceutical Group Limited (HKG:2877) as an attractive investment with its 7.2x P/E ratio.  However, the P/E might be low for a reason and it requires further investigation to determine if it's justified.    Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.  China Shineway Pharmaceutical Group could be doing better as its earnings have been going backwards lately while most other companies have been seeing positive earnings growth.   The P/E is probably low because investors think this poor earnings performance isn't going to get any better.  If you still like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.     View our latest analysis for China Shineway Pharmaceutical Group SEHK:2877 Price to Earnings Ratio vs Industry December 23rd 2025 If you'd like to see what analysts are forecasting going forward, you should check out our free report on China Shineway Pharmaceutical Group.  Does Growth Match The Low P/E?   There's an inherent assumption that a company should underperform the market for P/E ratios like China Shineway Pharmaceutical Group's to be considered reasonable.   Retrospectively, the last year delivered a frustrating 25% decrease to the company's bottom line.   Still, the latest three year period has seen an excellent 43% overall rise in EPS, in spite of its unsatisfying short-term performance.  Accordingly, while they would have preferred to keep the run going, shareholders would probably welcome the medium-term rates of earnings growth.     Turning to the outlook, the next three years should generate growth of 4.2%  per year as estimated by the one analyst watching the company.  That's shaping up to be materially lower than the 14% per year growth forecast for the broader market.  With this information, we can see why China Shineway Pharmaceutical Group is trading at a P/E lower than the market.  Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.    The Key Takeaway  While the price-to-earnings ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of earnings expectations.  As we suspected, our examination of China Shineway Pharmaceutical Group's analyst forecasts revealed that its inferior earnings outlook is contributing to its low P/E.  At this stage investors feel the potential for an improvement in earnings isn't great enough to justify a higher P/E ratio.  Unless these conditions improve, they will continue to form a barrier for the share price around these levels.      Don't forget that there may be other risks. For instance, we've identified   1 warning sign for China Shineway Pharmaceutical Group  that you should be aware of.   You might be able to find a better investment than China Shineway Pharmaceutical Group. If you want a selection of possible candidates, check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings). Mobile Infrastructure for Defense and DisasterThe next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.Get the investor briefing before the next round of contractsSponsored On Behalf of CiTechNew: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2593440711","isCrawlerRequest":true}